Chapter 27: Dyslipidemia Flashcards
Red Yeast Rice
Yeast grown on rice that contains naturally occurring HMG-CoA reductase inhibitors in low amounts
Cholesterol lowering drugs that cause liver damage
- niacin
- fibrates
- potentially statins and ezetimibe
These drugs should not be used if ALT or AST is >3x ULN
Statin MOA
Inhibit the enzyme HMG-CoA reductase, which prevents the conversion of HMG-CoA to mevalonate. This is the rate limiting step in cholesterol synthesis.
High Intensity Statins
Atorvastatin 40-80mg
Rosuvastatin 20-40mg
Low Intensity Statins
"She Probably Loves Fore Play" S- simvastatin 10mg P- pravastatin 10-20mg L- lovastatin 20mg F- fluvastatin 20-4mg P- pitavastatin 1mg
Ezetimibe MOA
Inhibits absorption of cholesterol in the small intestine
-Monitor LFTS, avoid use in active liver disease
PCSK-9 inhibitors
Block the ability of PCSK9 to bind to the LDL receptor . PCSK9 is an enzyme that increases LDL receptor degradation, LDL receptor clears circulating LDL. PCSK9 inhibitors decrease LDL dramatically.
Bile Acid Sequestrants/Bile Acid Binding Resins MOA
Work by binding bile acids in the intestines, forming a complex that is excreted in the feces. This non-systemic action results in a partial removal of the bile-acids from the enterohepatic circulation, preventing their reabsorption.
-CI in TG>500
Fibrates MOA
Peroxisome proliferate receptor alpha (PPARA) activators, which upregulate the expression of apoC-II and apoA-I.
ApoC-II increases lipoprotein lipase activity leading to catabolism of VLDL.
Can lead to increased LDL
Gemfibrozil CI
Do not use with repaglinide (can increase hypoglycemia)
Should not be given with ezetimibe or statins
Niacin MOA
Decreases the rate of hepatic synthesis of VLDL (decreases TG) and LDL. Also alters the binding of HDL particles to scavenger receptor B-1 in the liver.
-Also know as nicotinic acid or B-3
Fish Oil MOA
- not completely understood
- Indicated for TG >500 as an adjunct to diet
- Lovaza can increase LDL
Juxtapid (lomitapide) MOA
- REMS
- decreases apoB, the main component of LDL and VLDL. Binds to and inhibits microsomal triglyceride transfer protein (MTP) which prevents the assembly of apoB containing lipoproteins.
- approved for homozygous familial hypercholesterolemia (HoFH)